Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Cardiology/Vascular Diseases | Gastroenterology | Hematology | Nephrology | Neurology | Oncology | Pulmonary/Respiratory Diseases
View By:YearCompanyConditionsTherapeutic AreasDrug Names
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Approval Status: Approved April 1996
Treatment Area: diagnosis of disease in major organs
Visipaque is a contrast agent that allows doctors to better
diagnose diseases of the heart, brain, kidney, blood vessels and
other major organs.
Contrast agents, in general, are fluids that are injected into a
subject's blood stream to enhance the images, or pictures, of
certain body organ structures or processes obtained during
diagnostic imaging procedures. This enhancement enables physicians
to more accurately detect, diagnose, and properly treat disease,
states, and functional abnormalities, such as tumors and
Each year, as many as 18 million subjects in the United States
undergo X-rays and other diagnostic procedures that require the
administration of contrast media to aid in the detailed
visualization of internal organs and tissues.